{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:37:25Z","timestamp":1778629045710,"version":"3.51.4"},"reference-count":29,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"DOI":"10.1590\/1414-431x2024e13627","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:02:12Z","timestamp":1728306132000},"source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of convalescent plasma in hospitalized COVID-19 patients: findings from a controlled trial"],"prefix":"10.1590","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3465-7444","authenticated-orcid":false,"given":"T.P.","family":"Costa","sequence":"first","affiliation":[{"name":"Maternidade e Cirurgia Nossa Senhora do Rocio-HR,  Brasil; Instituto Carlos Chagas, Funda\u00e7\u00e3o Oswaldo Cruz,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5166-2897","authenticated-orcid":false,"given":"M.","family":"Aoki","sequence":"additional","affiliation":[{"name":"Instituto Carlos Chagas, Funda\u00e7\u00e3o Oswaldo Cruz,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6972-5830","authenticated-orcid":false,"given":"C.M.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Instituto de Pesquisa do Vale da Ci\u00eancia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6840-5114","authenticated-orcid":false,"given":"E.","family":"Socca","sequence":"additional","affiliation":[{"name":"Instituto de Pesquisa do Vale da Ci\u00eancia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8463-4793","authenticated-orcid":false,"given":"L.","family":"Itinose","sequence":"additional","affiliation":[{"name":"Maternidade e Cirurgia Nossa Senhora do Rocio-HR,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7816-4394","authenticated-orcid":false,"given":"R.","family":"Basso","sequence":"additional","affiliation":[{"name":"Maternidade e Cirurgia Nossa Senhora do Rocio-HR,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2929-6696","authenticated-orcid":false,"given":"L.","family":"Blanes","sequence":"additional","affiliation":[{"name":"Instituto Carlos Chagas, Funda\u00e7\u00e3o Oswaldo Cruz,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung IF","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1378\/chest.12-2907","article-title":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection","volume":"144","author":"Hung IFN","year":"2013","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins J","year":"2015","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/ijms23010029","article-title":"Analysis of immune escape variants from antibody-based therapeutics against COVID-19: a systematic review","volume":"23","author":"Focosi D","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'kovski P","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41590-022-01248-5","article-title":"The humoral response and antibodies against SARS- CoV-2 infection","volume":"23","author":"Qi H","year":"2022","journal-title":"Nat Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/S1473-3099(22)00311-5","article-title":"Monoclonal antibody therapies against SARS-CoV-2","volume":"22","author":"Focosi D","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"ref9","first-page":"734","article-title":"The rise of SARS-CoV-2 variants and the role of convalescent plasma therapy for management of infections","volume":"11","author":"Moubarak M","year":"2021","journal-title":"Life (Basel)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2213-2600(22)00050-9","article-title":"Convalescent plasma in outpatients with COVID-19","volume":"10","author":"Focosi D","year":"2022","journal-title":"Lancet Respir Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"106204","DOI":"10.1016\/j.ijsu.2021.106204","article-title":"Convalescent plasma therapy against the emerging SARS-CoV-2 variants: delineation of the potentialities and risks","volume":"97","author":"Dhawan M","year":"2022","journal-title":"Int J Surg"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(21)00897-7","article-title":"Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa2033700","article-title":"Early high-titer plasma therapy to prevent severe Covid-19 in older adults","volume":"384","author":"Libster R","year":"2021","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e0020021","DOI":"10.1128\/cmr.00200-21","article-title":"COVID-19 convalescent plasma and clinical trials: understanding conflicting outcomes","volume":"35","author":"Focosi D","year":"2022","journal-title":"Clinl Microbiol Rev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e158190","DOI":"10.1172\/JCI158190","article-title":"Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response","volume":"132","author":"Marconato M","year":"2022","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/CCM.0b013e3182771386","article-title":"Clinical research during a public health emergency: a systematic review of severe pandemic influenza management","volume":"41","author":"Ortiz JR","year":"2013","journal-title":"Critl Care Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s13054-020-03189-7","article-title":"Efficacy of convalescent plasma for the treatment of severe influenza","volume":"24","author":"Xu Z","year":"2020","journal-title":"Crit Care"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e03372","DOI":"10.1128\/mBio.03372-20","article-title":"The principles of antibody therapy for infectious diseases with relevance for COVID-19","volume":"12","author":"Casadevall A","year":"2021","journal-title":"mBio"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"105044","DOI":"10.1016\/j.isci.2022.105044","article-title":"The mechanisms of immune response and evasion by the main SARS-CoV-2 variants","volume":"25","author":"Chen Q","year":"2022","journal-title":"iScience"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"100882","DOI":"10.1016\/j.drup.2022.100882","article-title":"The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies","volume":"65","author":"Focosi D","year":"2022","journal-title":"Drug Resist Updat"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor- binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli L","year":"2020","journal-title":"Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies","volume":"21","author":"Cox M","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"ref23"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cell.2021.12.046","article-title":"SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses","volume":"185","author":"Dejnirattisai W","year":"2022","journal-title":"Cell"},{"key":"ref25"},{"key":"ref26"},{"issue":"21","key":"ref27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12939-022-01729-x","article-title":"Inequality in the distribution of Covid-19 vaccine: a systematic review","volume":"30","author":"Bayati M","year":"2022","journal-title":"Int J Equity Health"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/s41591-021-01488-2","article-title":"Convalescent Plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial","volume":"27","author":"B\u00e9gin P","year":"2021","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1101\/gr.276175.121","article-title":"Plasma cell-free RNA characteristics in COVID-19 patients","volume":"32","author":"Wang Y","year":"2022","journal-title":"Genome Res"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0100-879X2024000100681&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:02:21Z","timestamp":1728306141000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2024000100681&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":29,"alternative-id":["S0100-879X2024000100681"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x2024e13627","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"value":"1414-431X","type":"electronic"},{"value":"0100-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e13627"}}